EMMANUEL AMOAH: Open Payments
NPI 1659124352 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,653 in 61 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $347 · 2025 $1,653
Food & beverage: $1,653
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 17 | $603 |
| ABBVIE INC. | 7 | $216 |
| Janssen Biotech, Inc. | 8 | $187 |
| Ardelyx, Inc. | 10 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $123 |
| Lilly USA, LLC | 3 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Gilead Sciences, Inc. | 2 | $40 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| RedHill Biopharma Inc. | 1 | $37 |
Products named: REZDIFFRA, TREMFYA, IBSRELA, MAVYRET, OMVOH, ENTYVIO, EOHILIA, XIFAXAN.
Industry payments across PA — which companies pay providers there.
